We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$37M
1-Year Est. Return
63.54%
This Fund
S&P 500
This Quarter
Est. Return
+7.83%
1 Year Est. Return
+63.54%
3 Year Est. Return
+38.32%
5 Year Est. Return
+47.02%
10 Year Est. Return
+2,091.28%
AUM
$658M
AUM Growth
-$44.8M
(-6.4%)
Cap. Flow
+$23.4M
Cap. Flow
% of AUM
3.56%
Top 10 Holdings %
Top 10 Hldgs %
35.22%
Holding
143
New
39
Increased
27
Reduced
22
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Smith & Nephew
SNN
|
+$10.3M |
| 2 |
STAAR Surgical
STAA
|
+$7.04M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$6.66M |
| 4 |
Zimmer Biomet
ZBH
|
+$6.03M |
| 5 |
Avantor
AVTR
|
+$4.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$10.4M |
| 2 |
Axogen
AXGN
|
+$6.9M |
| 3 |
CELG
Celgene Corp
CELG
|
+$4.72M |
| 4 |
Axsome Therapeutics
AXSM
|
+$4.13M |
| 5 |
Globus Medical
GMED
|
+$3.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.26% |
| 2 | Healthcare | 47.69% |
| 3 | Industrials | 1.24% |
| 4 | Consumer Staples | 0.68% |
| 5 | Materials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$795B
| $44M | 6.67% |
150,000
-160,000
| -52% | -$46.1M |
|
2
PUT
iShares Russell 2000 ETF
IWM
$76.5B
| $34.2M | 5.2% |
220,000
-222,500
| -50% | -$34.3M |
|
3
Inspire Medical Systems
INSP
$2.1B
| $24.3M | 3.68% |
400,000
+41,500
| +12% | +$2.24M |
|
4
PUT
iShares US Medical Devices ETF
IHI
$3.27B
| $24.1M | 3.66% |
600,000
+300,000
| +100% | +$11.4M |
|
|
NSTG
5
DELISTED
NanoString Technologies, Inc.
NSTG
| $21.9M | 3.32% |
720,915
+69,474
| +11% | +$1.84M |
|
6
ICU Medical
ICUI
$3.89B
| $19.9M | 3.03% |
79,119
+5,500
| +7% | +$1.27M |
|
|
7
Zimmer Biomet
ZBH
$18.5B
| $18.8M | 2.86% |
164,800
+51,500
| +45% | +$6.03M |
|
|
8
STAAR Surgical
STAA
$1.12B
| $15.8M | 2.4% |
538,600
+243,758
| +83% | +$7.04M |
|
9
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.14B
| $15.5M | 2.35% |
200,000
-175,000
| -47% | -$13M |
|
10
PUT
Amplify Alternative Harvest ETF
MJ
$110M
| $13.5M | 2.04% |
35,417
+2,084
| +6% | +$841K |
|
|
BHVN
11
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $13.1M | 2% |
+300,000
| New | +$16.9M |
|
12
CALL
Becton Dickinson
BDX
$49.5B
| $12.6M | 1.91% |
+51,250
| New | +$11.9M |
|
13
CALL
Stryker
SYK
$109B
| $12.3M | 1.87% |
60,000
+10,000
| +20% | +$1.91M |
|
14
PUT
Guardant Health
GH
$23.5B
| $12.3M | 1.86% |
142,200
+28,400
| +25% | +$2.17M |
|
|
ARQL
15
CALL
DELISTED
Arqule Inc
ARQL
| $11.7M | 1.78% |
+1,063,700
| New | +$7.4M |
|
|
16
Smith & Nephew
SNN
$11.6B
| $10.9M | 1.65% |
+250,000
| New | +$10.3M |
|
17
Establishment Labs
ESTA
$2.12B
| $10.8M | 1.63% |
489,490
+167,765
| +52% | +$4.01M |
|
18
Boston Scientific
BSX
$63.6B
| $10.1M | 1.53% |
235,000
+25,000
| +12% | +$962K |
|
|
19
CALL
ICU Medical
ICUI
$3.89B
| $10.1M | 1.53% |
+40,000
| New | +$9.27M |
|
20
DexCom
DXCM
$33B
| $9.33M | 1.42% |
249,148
-10,000
| -4% | -$314K |
|
21
CALL
Incyte
INCY
$25.3B
| $8.5M | 1.29% |
+100,000
| New | +$8.03M |
|
|
22
PUT
Globus Medical
GMED
$10.1B
| $8.46M | 1.28% |
+200,000
| New | +$8.69M |
|
|
RCM
23
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.14M | 1.24% |
647,141
+190,000
| +42% | +$2.15M |
|
24
PUT
iRhythm Holdings
IRTC
$3.69B
| $7.91M | 1.2% |
100,000
+25,000
| +33% | +$1.82M |
|
|
AGN
25
DELISTED
Allergan plc
AGN
| $7.89M | 1.2% |
47,109
+4,984
| +12% | +$690K |
|
Similar funds
MAM
GSEP
CTC
XA
YEPI
PEP
CP
WTG
Pura Vida Investments's Q2 2019 Portfolio in Review
As of Q2 2019, Pura Vida Investments held 143 positions worth $658M, down 6.4% from $703M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Pura Vida Investments deployed $23.4M of net new capital in Q2 2019, opening 39 new positions and adding to 27 existing holdings. Its largest new stake was Smith & Nephew: 250,000 shares worth $10.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 59% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Axsome Therapeutics, an estimated $4.13M trimmed.
- Pura Vida Investments's largest Q2 2019 buy was Smith & Nephew: 250,000 shares worth $10.9M.
- Pura Vida Investments added most to STAAR Surgical in Q2 2019, an estimated $7.04M increase.
- Pura Vida Investments's biggest Q2 2019 reduction was Axsome Therapeutics, cutting an estimated $4.13M.
- Pura Vida Investments fully exited Dentsply Sirona in Q2 2019, selling an estimated $10.4M.
- Pura Vida Investments's ten largest holdings make up 35% of its $658M portfolio in Q2 2019.
- Pura Vida Investments opened 39 new positions and closed 45 in Q2 2019.
- Pura Vida Investments's portfolio value fell 6.4% quarter-over-quarter to $658M.
Based on Pura Vida Investments's 13F filing for Q2 2019, filed 14 Aug 2019.